NASDAQ:CYNA CYNA (CYNA) Stock Price, News & Analysis → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free CYNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$40.48▼$40.4850-Day Range N/A52-Week Range$10.54▼$40.67VolumeN/AAverage Volume113,889 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get CYNA alerts: Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy About CYNA Stock (NASDAQ:CYNA)Cynapsus Therapeutics Inc is a Canada-based specialty central nervous system (CNS) pharmaceutical company. It develops a sublingual thin film for the potential treatment for on-demand management of debilitating OFF episodes associated with Parkinson’s disease (PD). The Company completed a Phase two clinical trial for its product candidate, APL-130277, a sublingual formulation of apomorphine hydrochloride, or apomorphine. Apomorphine is the only molecule approved for acute, intermittent treatment of OFF episodes for advanced PD patients, but is currently only approved as a subcutaneous injection in the United States. APL-130277 is a turning ON medication designed to convert a PD patient from the OFF to the ON state while avoiding the issues associated with subcutaneous delivery of apomorphine. It is designed to convert all types of OFF episodes, including morning OFF episodes. Furthermore, the Company has initiated its pivotal Phase three clinical program for APL-130277.Read More Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy CYNA Stock News HeadlinesApril 11, 2024 | msn.comAmber Rose Responds to Chris Rock Dating Rumors, Reveals the A-List Actress She's Friends With (Exclusive)November 30, 2023 | msn.comSearch underway for 2 men in Robeson Co. jewelry store robberyApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.October 27, 2023 | msn.comBlac Chyna Opens Up About 'Custody Battle' with Tyga for Son King: 'Can't Wait Until It's Over'October 21, 2023 | mirror.co.ukBBC's Strictly Come Dancing's Neil Jones and fiancée put on loved up displayOctober 6, 2023 | msn.comBlac Chyna reduced to selling clothes, purses for money amid legal battle with TygaOctober 5, 2023 | msn.comStrictly Come Dancing's Katya Jones says 'you won't find us' after sending message to ex-husband over baby newsOctober 3, 2023 | msn.comBlac Chyna selling her personal belongings ‘to make ends meet’ amid custody battle with TygaApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.September 28, 2023 | msn.comBlac Chyna Debuts Romance With Songwriter Derrick MilanoSeptember 18, 2023 | msn.comBlac Chyna Breaks Down In Emotional Reunion With Her Mom To Celebrate 1 Year SobrietySeptember 15, 2023 | msn.comCiara Cracks Up Laughing When Asked About Co-Parenting With Ex-Fiancé FutureAugust 10, 2023 | msn.comBlac Chyna Shares Rare Photo of Son King, 10, Honing Soccer Skills: 'Passionate About His Craft'August 10, 2023 | msn.comWhat sex tape scandal? Prince Kaybee set to release new single amid Cyan Boujee dramaAugust 2, 2023 | msn.comNASA Wallops plans launch of Antares rocket to International Space StationJuly 9, 2023 | startribune.comJuanita Mary Martha 'Corky' (Corbett) SwartoutJune 24, 2023 | msn.comEagles 'Excellent' Secondary Rankings: Best in NFL?June 24, 2023 | msn.comTroy Police Department blotterJune 14, 2023 | msn.comTo lawyers, Trump is a kryptonite clientJune 14, 2023 | msn.com2 men seriously injured following crash on H-3 Freeway in KaneoheJune 13, 2023 | msn.comPaul Heyman reveals that WWE already has the next John Cena under contractJune 6, 2023 | finance.yahoo.comVistagen Announces Stockholder-Approved Reverse Stock SplitMay 24, 2023 | msn.comMile posts: Items on Tyrice Taylor, Aisha Ramone, Andrew Hutchinson, Ryan Harvey, Lily Campbell, Lexi BrownMay 5, 2023 | msn.comHypnotizing people before surgery becoming common worldwideApril 8, 2023 | msn.comLost dog found in South Carolina passes away after reuniting with owner 7 years laterMarch 15, 2023 | msn.comAbaba pounds out superb 69, leads by 4March 14, 2023 | msn.comPeering Into Edison Intl's Recent Short InterestSee More Headlines Receive CYNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CYNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/10/2016Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:CYNA Previous SymbolOTCMKTS:CYNAF CUSIPN/A CIK1532079 Webwww.cynapsus.ca Phone+1-416-7032449FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report CYNA Stock Analysis - Frequently Asked Questions How were CYNA's earnings last quarter? CYNA (NASDAQ:CYNA) posted its quarterly earnings results on Wednesday, August, 10th. The biotechnology company reported ($0.83) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.77) by $0.06. What other stocks do shareholders of CYNA own? Based on aggregate information from My MarketBeat watchlists, some companies that other CYNA investors own include Corbus Pharmaceuticals (CRBP), Synthetic Biologics (SYN), Aralez Pharmaceuticals (ARLZ), RedHill Biopharma (RDHL), Zynerba Pharmaceuticals (ZYNE), Catalyst Pharmaceuticals (CPRX), National Grid (NG), Protagonist Therapeutics (PTGX) and StoneMor (STON). When did CYNA IPO? CYNA (CYNA) raised $64 million in an initial public offering (IPO) on Thursday, June 18th 2015. The company issued 4,500,000 shares at a price of $14.18 per share. BofA Merrill Lynch served as the underwriter for the IPO and Nomura and Noble Life Science Partners were co-managers. This page (NASDAQ:CYNA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CYNA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
